Reappointment of Ms. Naina Lal Kidwai, Independent Director
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gland Pharma shareholders have approved the reappointment of Ms. Naina Lal Kidwai as an Independent Director for a second term of five consecutive years (May 17, 2026 to May 16, 2031). The reappointment was passed through postal ballot e-voting. Ms. Kidwai is a prominent business leader, currently serving as Chairman of Rothschild & Co India and holding board positions at Holcim, UPL, and Biocon. She previously chaired HSBC India and served as President of FICCI. Shareholders also approved commission on profits as remuneration for her services.
This is a routine corporate governance event confirming board continuity with an experienced independent director. No material impact on stock price expected as this is a standard reappointment of an established board member.